GWREI Group, LLC

CIK: 2105728•CA•Incorporated: 2024-10-09

Latest Reported Offering

$50,000
Target Amount
$1,000,000
Maximum Amount
2026-08-22
Deadline

Security Details

Type: Debt
Price per share: $1.00
Price set by: Revenue participation convertible note
Shares offered: 0+

Offering Costs

Cash commission: 4%
of capital raised during the offering, plus pass-through fees associated with background checks, escrow due diligence fees, and transactional fees charged by third party vendors of the platform. Investors pay a 2% fee at the time of investment.
Equity compensation: —
N/A

Filing history

Form C family — 2 filings
FiledFormFile numberPortalWhat it statesWhat the filer said
2026-04-23C-U020-36838FundingHope$50K target, up to $1M · Debt at $1.00 · closes 2026-08-22We have achieved a 100% raise of our initial target offering amount. The total amount raised was $50,000.00 from a total of 1 investor, on date 4/22/26
2026-02-23C020-36838FundingHope$50K target, up to $1M · Debt at $1.00 · closes 2026-08-22—
Embarc dashboard

Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.

  • Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
  • A sparkline on each figure so the shape is visible before the numbers
  • A revenue series dated to the filings that reported it
  • The campaign as filed: target, ceiling, deadline, and the portal that ran it
  • Follow it, and see it change on your watchlist
Open in the dashboard

Company Information

Legal Status
Limited Liability Company
Jurisdiction
CA
Date of Incorporation
2024-10-09

Latest Metrics

Employees2
Total Assets$73,452
Cash on Hand$49,989
Revenues$454,366
Net Income$68,626

Crowdfunding Portals

The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.